<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[5, 7] placebo-<br>[21, 22] dexamethasone<br>[86, 87] dexamethasone<br>[88, 89] placebo<br>[127, 128] dexamethasone<br>[140, 141] placebo<br>[154, 155] granisetron<br>[156, 160] dexamethasone pre-chemotherapy<br>[162, 163] granisetron<br>[212, 213] fluorouracil/epirubicin/cyclophosphamide<br>[216, 218] doxorubicin/cyclophosphamide.<br>[275, 277] dexamethasone;<br>[345, 346] dexamethasone<br>[347, 348] placebo<br></td>
<td width=33%>
[5, 7] placebo-<br>[21, 22] dexamethasone<br>[27, 29] adjuvant chemotherapy<br>[51, 53] adjuvant chemotherapy<br>[60, 61] dexamethasone<br>[79, 80] chemotherapy<br>[86, 87] dexamethasone<br>[88, 89] placebo<br>[126, 128] oral dexamethasone<br>[140, 141] placebo<br>[154, 155] granisetron<br>[156, 163] dexamethasone pre-chemotherapy and oral granisetron<br>[212, 213] fluorouracil/epirubicin/cyclophosphamide<br>[216, 218] doxorubicin/cyclophosphamide.<br>[239, 240] placebo<br>[275, 277] dexamethasone;<br>[317, 319] dexamethasone.<br>[345, 346] dexamethasone<br>[347, 348] placebo<br>[351, 353] adjuvant chemotherapy<br></td>
<td width=33%>
[5, 8] placebo-controlled<br>[21, 22] dexamethasone<br>[27, 29] adjuvant chemotherapy<br>[51, 53] adjuvant chemotherapy<br>[60, 61] dexamethasone<br>[79, 80] chemotherapy<br>[86, 89] dexamethasone or placebo<br>[109, 111] treatments.<br>[126, 144] oral dexamethasone (4mg twice daily for 2days) versus placebo for chemotherapy-<br>[153, 163] intravenous granisetron and dexamethasone pre-chemotherapy and oral granisetron<br>[212, 213] fluorouracil/epirubicin/cyclophosphamide<br>[216, 218] doxorubicin/cyclophosphamide.<br>[239, 240] placebo<br>[275, 277] dexamethasone;<br>[317, 319] dexamethasone.<br>[345, 348] dexamethasone or placebo<br>[351, 354] adjuvant chemotherapy.<br></td>
</tr>
